A new survey into the anti-depressant qualities of a short-acting psychedelic has reported extraordinarily positive improvements in well-being. The research, led by a team from Johns Hopkins University, suggests the brief duration of action seen in the drug 5-MeO-DMT makes it potentially more useful in clinical applications than longer acting psychedelics such as psilocybin and LSD.

Dimethyltryptamine, or DMT, was once described by counter-culture figurehead Timothy Leary as the “nuclear bomb of the psychedelic family.” Its effects come on fast, often within a minute of being inhaled or injected, and tend to only last for anywhere from 10 to 30 minutes. For this reason it became anecdotally known as the “businessman’s trip” – a psychedelic one could effectively take in a lunch break.

Read from original article

Short-acting psychedelic offers promising new treatment pathway for depression and anxiety

Short-acting psychedelic offers promising new treatment pathway for depression and anxiety